{"id":"NCT00576823","sponsor":"Sanofi","briefTitle":"Alfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic Etiology","officialTitle":"12-week, Multicenter, Open-label, Non-comparative Study to Investigate Pharmacodynamic and Safety of Alfuzosin 0.2 mg/kg/Day in the Treatment of Children and Adolescents 2 - 16 Years of Age With Hydronephrosis Associated With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology Followed by a 40-week Open-label Extension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-12","primaryCompletion":"2009-01","completion":"2009-10","firstPosted":"2007-12-19","resultsPosted":"2011-02-08","lastUpdate":"2014-10-29"},"enrollment":25,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hydronephrosis","Neurogenic Bladder"],"interventions":[{"type":"DRUG","name":"Alfuzosin","otherNames":["SL770499"]}],"arms":[{"label":"Alfuzosin solution - 2-7 years","type":"EXPERIMENTAL"},{"label":"Alfuzosin solution - 8-16 years","type":"EXPERIMENTAL"},{"label":"Alfuzosin tablet - 8-16 years","type":"EXPERIMENTAL"}],"summary":"Primary objective was to determine efficacy of Alfuzosin in the treatment of children and adolescents 2-16 years of age with newly diagnosed or progressive hydronephrosis due to elevated detrusor Leak Point Pressure \\[LPP\\] of neuropathic etiology.\n\nSecondary objectives were:\n\n* To investigate the safety and tolerability of alfuzosin 0.2 mg/kg/day in children and adolescents,\n* To investigate the number of Urinary Tract Infection (UTI) episodes,\n* To investigate the pharmacokinetics of Alfuzosin (population kinetics).","primaryOutcome":{"measure":"Number of Participants With a Decrease From Baseline ≥ 1 in the Society of Fetal Urology (SFU) Grade of Hydronephrosis","timeFrame":"baseline and 12 weeks (efficacy study phase)","effectByArm":[{"arm":"Alfuzosin Solution - 2-7 Years","deltaMin":2,"sd":null},{"arm":"Alfuzosin Solution - 8-16 Years","deltaMin":5,"sd":null},{"arm":"Alfuzosin Tablet - 8-16 Years","deltaMin":3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":9},"locations":{"siteCount":12,"countries":["Bulgaria","Canada","Estonia","India","Malaysia","Poland","Russia","Serbia","Singapore","Slovakia","Taiwan","Turkey (Türkiye)"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":12},"commonTop":["CYSTITIS","NASOPHARYNGITIS","PYREXIA","PHARYNGITIS","UPPER RESPIRATORY TRACT INFECTION"]}}